These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 25465748)

  • 1. Relationships between antiparkinson medication nonadherence, regimen modifications, and healthcare utilization and expenditures.
    Wei YJ; Palumbo FB; Simoni-Wastila L; Shulman LM; Stuart B; Beardsley R; Brown C
    Parkinsonism Relat Disord; 2015 Jan; 21(1):36-41. PubMed ID: 25465748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiparkinson drug adherence and its association with health care utilization and economic outcomes in a Medicare Part D population.
    Wei YJ; Palumbo FB; Simoni-Wastila L; Shulman LM; Stuart B; Beardsley R; Brown CH
    Value Health; 2014 Mar; 17(2):196-204. PubMed ID: 24636377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiparkinson drug use and adherence in medicare part D beneficiaries with Parkinson's disease.
    Wei YJ; Palumbo FB; Simoni-Wastila L; Shulman LM; Stuart B; Beardsley R; Brown C
    Clin Ther; 2013 Oct; 35(10):1513-1525.e1. PubMed ID: 24139423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and cost of medication nonadherence in Parkinson's disease: evidence from administrative claims data.
    Davis KL; Edin HM; Allen JK
    Mov Disord; 2010 Mar; 25(4):474-80. PubMed ID: 20131374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns and associated costs with Parkinson's disease levodopa induced dyskinesia.
    Suh DC; Pahwa R; Mallya U
    J Neurol Sci; 2012 Aug; 319(1-2):24-31. PubMed ID: 22664154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON study.
    Tinazzi M; Abbruzzese G; Antonini A; Ceravolo R; Fabbrini G; Lessi P; Barone P;
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1130-5. PubMed ID: 23993249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of early nonadherence to oral antipsychotics on clinical and economic outcomes among patients with schizophrenia.
    Offord S; Lin J; Mirski D; Wong B
    Adv Ther; 2013 Mar; 30(3):286-97. PubMed ID: 23483449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Healthcare costs and nonadherence among chronic opioid users.
    Leider HL; Dhaliwal J; Davis EJ; Kulakodlu M; Buikema AR
    Am J Manag Care; 2011 Jan; 17(1):32-40. PubMed ID: 21348566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication adherence and associated outcomes in medicare health maintenance organization-enrolled older adults with Parkinson's disease.
    Kulkarni AS; Balkrishnan R; Anderson RT; Edin HM; Kirsch J; Stacy MA
    Mov Disord; 2008 Feb; 23(3):359-65. PubMed ID: 18074366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study.
    Faught RE; Weiner JR; Guérin A; Cunnington MC; Duh MS
    Epilepsia; 2009 Mar; 50(3):501-9. PubMed ID: 19183224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn's disease patients.
    Kane SV; Chao J; Mulani PM
    Adv Ther; 2009 Oct; 26(10):936-46. PubMed ID: 19838649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
    Touré JT; Brandt NJ; Limcangco MR; Briesacher BA
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):25-35. PubMed ID: 16730618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug prescribing patterns in Parkinson's disease: a pharmacoepidemiological survey in a cohort of ambulatory patients.
    Leoni O; Martignoni E; Cosentino M; Michielotto D; Calandrella D; Zangaglia R; Riboldazzi G; Oria C; Lecchini S; Nappi G; Frigo G
    Pharmacoepidemiol Drug Saf; 2002 Mar; 11(2):149-57. PubMed ID: 11998540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
    Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L
    Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).
    Fleisher JE; Dahodwala NA; Xie SX; Mayo M; Weintraub D; Chodosh J; Shea JA
    J Parkinsons Dis; 2016 Apr; 6(2):383-92. PubMed ID: 27061070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to antiparkinson medication in a multicenter European study.
    Grosset D; Antonini A; Canesi M; Pezzoli G; Lees A; Shaw K; Cubo E; Martinez-Martin P; Rascol O; Negre-Pages L; Senard A; Schwarz J; Strecker K; Reichmann H; Storch A; Löhle M; Stocchi F; Grosset K
    Mov Disord; 2009 Apr; 24(6):826-32. PubMed ID: 19191340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in RA patients' adherence to subcutaneous anti-TNF therapies and costs.
    Borah BJ; Huang X; Zarotsky V; Globe D
    Curr Med Res Opin; 2009 Jun; 25(6):1365-77. PubMed ID: 19425902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antiparkinsonian drugs in Denmark: results from a nationwide pharmacoepidemiological study.
    Brandt-Christensen M; Kvist K; Nilsson FM; Andersen PK; Kessing LV
    Mov Disord; 2006 Aug; 21(8):1221-5. PubMed ID: 16671076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.